The CRC Blueprint

My scientific approach to my own cancer – shared with you.

Australia

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers

Phase 2 · 220 people · 55 sites in 13 countries · Recruiting now

August 7, 2026
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Phase 2 · randomised · 1,109 people · 47 sites in 8 countries · Recruiting now

August 7, 2026
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer

Phase 2 · randomised · 108 people · 59 sites in 15 countries · Running, not taking new patients

August 7, 2026
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer

Phase 1 · randomised · 542 people · 84 sites in 11 countries · Recruiting now

August 7, 2026
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

Phase 2 · randomised · 90 people · 17 sites in 2 countries · Recruiting now

August 7, 2026
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Phase 2 · randomised · 80 people · 76 sites in 12 countries · Recruiting now

August 7, 2026
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

Phase 2 · randomised · 150 people · 10 sites in 2 countries · Recruiting now

August 7, 2026
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer

Phase 2 · randomised · 170 people · 14 sites in 4 countries · Recruiting now

August 7, 2026
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

Phase 2 · randomised · 390 people · 59 sites in 14 countries · Recruiting now

August 7, 2026
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Phase 3 · randomised · 800 people · 285 sites in 17 countries · Recruiting now

August 7, 2026